Physician profile
Andrew Miller
NPI 1093701476
$1,590.16
in general payments reported to CMS, 2019-2025
14 companies · $293 in 2025
The $293 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $53.01 · 2021: $214 · 2022: $69.10 · 2023: $269 · 2024: $468 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,030.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $313.16 | 2019-2025 | Citrefix, Actishield, Augment Injectable |
| Smith+Nephew, INC. | $312.11 | 2019-2025 | Grafix Pl, Stravix, Renasys Go V2 Home |
| Kerecis Limited | $199.73 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Organogenesis INC. | $189.60 | 2020-2022 | |
| Treace Medical Concepts, INC. | $144.18 | 2023-2025 | |
| Averitas Pharma INC. | $112.97 | 2023-2025 | Qutenza |
| Paragon 28, INC. | $110.39 | 2019-2024 | Mtp, Gorilla |
| Rock Medical Orthopedics, INC. | $101.72 | 2019-2024 | |
| Horizon Therapeutics Plc | $30.39 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $19.00 | 2025 | |
| Convatec INC. | $17.38 | 2023 | |
| Paratek Pharmaceuticals, INC. | $16.04 | 2025 | Nuzyra |
| Merck Sharp & Dohme LLC | $12.24 | 2019 | |
| Orthofix Medical, INC. | $11.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.